CRWM
ABBV icon

Castle Rock Wealth Management’s AbbVie ABBV Stock Holding History

Castle Rock Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$320K Sell
1,198
-317
-21% -$81.3K 0.06% 215
2026
Q2 		$380K Buy
1,515
+17
+1% +$3.66K 0.07% 196
2026
Q1 		$313K Sell
1,498
-67
-4% -$14.9K 0.07% 215
2025
Q4 		$355K Buy
1,565
+6
+0.4% +$1.37K 0.08% 199
2025
Q3 		$371K Buy
1,559
+10
+0.6% +$2.04K 0.08% 187
2025
Q2 		$288K Sell
1,549
-3,534
-70% -$657K 0.07% 213
2025
Q1 		$1.06M Sell
5,083
-2,055
-29% -$400K 0.29% 95
2024
Q4 		$1.38M Buy
7,138
+341
+5% +$62.7K 0.33% 87
2024
Q3 		$1.32M Buy
6,797
+119
+2% +$22.2K 0.32% 90
2024
Q2 		$1.14M Buy
6,678
+205
+3% +$34K 0.28% 100
2024
Q1 		$1.05M Buy
6,473
+431
+7% +$74.3K 0.29% 106
2023
Q4 		$977K Sell
6,042
-47
-0.8% -$6.85K 0.3% 91
2023
Q3 		$905K Buy
6,089
+2,511
+70% +$369K 0.3% 83
2023
Q2 		$492K Buy
3,578
+194
+6% +$28.4K 0.17% 128
2023
Q1 		$497K Buy
3,384
+15
+0.4% +$2.29K 0.18% 125
2022
Q4 		$497K Sell
3,369
-196
-5% -$30.1K 0.22% 122
2022
Q3 		$504K Buy
+3,565
New +$512K 0.25% 106
2020
Q3 		– Sell
-6,029
Closed -$569K – 163
2020
Q2 		$569K Buy
6,029
+1,757
+41% +$155K 0.33% 103
2020
Q1 		$384K Sell
4,272
-4,797
-53% -$409K 0.33% 79
2019
Q4 		$871K Buy
9,069
+751
+9% +$62.3K 0.78% 40
2019
Q3 		$713K Buy
8,318
+866
+12% +$59.4K 0.74% 42
2019
Q2 		$545K Buy
+7,452
New +$586K 0.6% 60
2018
Q4 		– Sell
-4,719
Closed -$395K – 10
2018
Q3 		$395K Sell
4,719
-30
-0.6% -$2.85K 0.63% 54
2018
Q2 		$440K Buy
4,749
+791
+20% +$77.3K 0.6% 63
2018
Q1 		$375K Sell
3,958
-1,153
-23% -$127K 0.62% 57
2017
Q4 		$494K Buy
+5,111
New +$482K 0.96% 36

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Castle Rock Wealth Management's ABBV Position: Q3 2026 in Review

Castle Rock Wealth Management reduced its AbbVie (ABBV) stake by 21% in Q3 2026, selling an estimated $81.3K and leaving 1,198 shares worth $320K. The position accounts for 0.06% of the portfolio, ranked #215.

Castle Rock Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 26 quarters since. The position peaked at $1.38M in Q4 2024. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Castle Rock Wealth Management held 1,198 shares of AbbVie worth $320K as of Q3 2026.
  • Castle Rock Wealth Management sold 317 AbbVie shares in Q3 2026, an estimated $81.3K.
  • AbbVie made up 0.06% of Castle Rock Wealth Management's portfolio in Q3 2026, its #215 holding.
  • Castle Rock Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 26 quarters since.
  • Castle Rock Wealth Management's AbbVie position peaked at $1.38M in Q4 2024.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Castle Rock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.